Notes And Other Explanatory Information [Abstract]
| Concept |
2022-10-01 to 2023-09-30 |
|---|---|
| Notes and other explanatory information [abstract] | |
| Disclosure of accrued expenses and other liabilities [text block] |
25 Abgegrenzte
|
| Disclosure of auditors' remuneration [text block] |
Honorare des Abschlussprüfers
|
| Disclosure of authorisation of financial statements [text block] |
Der zum 30. September 2023 aufgestellte Konzernabschluss sowie der Konzernlagebericht wurden am 29. November
|
| Disclosure of borrowings [text block] |
24 Finanzielle
|
| Disclosure of cash and cash equivalents [text block] |
20 Zahlungsmittel
|
| Disclosure of changes in accounting policies, accounting estimates and errors [text block] |
Neue und geänderte Rechnungslegungsvorschriften
|
| Disclosure of collateral [text block] |
13 Sachanlagen
|
| Disclosure of commitments [text block] |
31 Haftungsverhältnisse
|
| Disclosure of debt instruments [text block] |
22 Pensionsrückstellungen
|
| Disclosure of deferred income [text block] |
26 Übrige
|
| Disclosure of depreciation and amortisation expense [text block] |
12 Übrige
|
| Disclosure of dividends [text block] |
lagen
|
| Disclosure of earnings per share [text block] |
10 Ergebnis
|
| Disclosure of effect of changes in foreign exchange rates [text block] |
8
|
| Disclosure of employee benefits [text block] |
7
|
| Disclosure of entity's operating segments [text block] |
32 Segmentberichterstattung
|
| Disclosure of events after reporting period [text block] |
38 Ereignisse
|
| Disclosure of fair value measurement [text block] |
27 Zusätzliche
|
| Disclosure of fee and commission income (expense) [text block] |
18 Übrige
|
| Disclosure of financial instruments designated at fair value through profit or loss [text block] |
Die Fair-Value-Option des IFRS 9 wird nicht angewendet.
|
| Disclosure of going concern [text block] |
Der vorliegende Konzernabschluss der Carl Zeiss Meditec AG, bestehend aus Konzern-Gewinn- und Verlustrechnung,
|
| Disclosure of government grants [text block] |
Zuwendungen der öffentlichen Hand
|
| Disclosure of impairment of assets [text block] |
11 Geschäfts-
|
| Disclosure of income tax [text block] |
9
|
| Disclosure of information about employees [text block] |
Die Personalzahlen (Mitarbeiter) sowie -struktur der Gruppe stellen sich wie folgt dar:
|
| Disclosure of information about key management personnel [text block] |
34 Beziehungen
|
| Disclosure of interests in other entities [text block] |
3
|
| Disclosure of inventories [text block] |
te
|
| Disclosure of investments accounted for using equity method [text block] |
14 At-equity
|
| Disclosure of liquidity risk [text block] |
36 Finanzielles
|
| Disclosure of non-controlling interests [text block] |
4
|
| Disclosure of objectives, policies and processes for managing capital [text block] |
37 Zusätzliche
|
| Disclosure of other operating expense [text block] |
6
|
| Disclosure of other provisions, contingent liabilities and contingent assets [text block] |
23 Übrige
|
| Disclosure of revenue [text block] |
5
|
| Disclosure of tax receivables and payables [text block] |
19 Übrige
|
| Disclosure of trade and other receivables [text block] |
17 Forderungen
|